Sumitomo Dainippon Pharma Oncology, Inc.

Cambridge,  MA 
United States
https://www.sdponcology.com

• Booth: 2025a

Sumitomo Dainippon Pharma Oncology, Inc., is a wholly owned subsidiary of Sumitomo Dainippon Pharma Co., Ltd. As a global oncology organization with teams in the U.S. and Japan, SDP Oncology is relentlessly committed to advancing purposeful science by transforming new discoveries into meaningful treatments for patients with cancer. The company's robust and diverse pipeline of preclinical and advanced-stage assets spans multiple areas, including oncogenic pathways, survival mechanisms and novel protein interactions, which aim to address unmet clinical needs in oncology.

Brands: https://havaspulse.com/open.php?assetid=4307844&t=r&s=rLakolNeKViLXHfb&filename=1143909-DSP-L02_ASCO_2021_Profile_Banner_1140x250.jpg

 Show Specials

• Discovery and the Promise of Purposeful Science (May 10, 2021)
  https://youtu.be/gfspH5bXtLE

 Press Releases

• Pipeline (May 10, 2021)
  https://www.sdponcology.com/pipeline/?utm_source=2021_asco&utm_medium=sdpo_profile_page&utm_campaign=text_link_pipeline

• Clinical Trials (May 10, 2021)
  https://www.sdponcology.com/pipeline/clinical-trials/?utm_source=2021_asco&utm_medium=sdpo_profile_page&utm_campaign=text_link_clinical_trials

• Cancer Vaccines Story (May 10, 2021)
  https://www.sdponcology.com/science/research/cancer-vaccines/?utm_source=2021_asco&utm_medium=sdpo_profile_page&utm_campaign=text_link_wt1_hla

• About Us (May 10, 2021)

  https://www.sdponcology.com/about/?utm_source=2021_asco&utm_medium=sdpo_profile_page&utm_campaign=text_link_about

• Pipeline (PDF downloadable) (May 13, 2021)
  https://www.sdponcology.com/?utm_source=2021_asco&utm_medium=sdpo_profile_page&utm_campaign=text_link_pipeline_pdf

 Products